Market open
Whitehawk Therapeutics/$WHWK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Whitehawk Therapeutics
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
Ticker
$WHWK
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
40
ISIN
US00032Q1040
Website
WHWK Metrics
BasicAdvanced
$80M
1.88
$0.91
0.51
-
Price and volume
Market cap
$80M
Beta
0.51
52-week high
$3.81
52-week low
$1.21
Average daily volume
149K
Financial strength
Current ratio
18.952
Quick ratio
18.825
Interest coverage (TTM)
-630.48%
Management effectiveness
Return on assets (TTM)
-21.92%
Return on equity (TTM)
17.69%
Valuation
Price to earnings (TTM)
1.881
Price to revenue (TTM)
1.87
Price to book
0.31
Price to tangible book (TTM)
0.31
Growth
Revenue change (TTM)
16.51%
Earnings per share change (TTM)
-135.80%
3-year revenue growth (CAGR)
103.27%
3-year earnings per share growth (CAGR)
-53.01%
What the Analysts think about WHWK
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Whitehawk Therapeutics stock.
WHWK Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
WHWK Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
WHWK News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Whitehawk Therapeutics stock?
Whitehawk Therapeutics (WHWK) has a market cap of $80M as of May 19, 2025.
What is the P/E ratio for Whitehawk Therapeutics stock?
The price to earnings (P/E) ratio for Whitehawk Therapeutics (WHWK) stock is 1.88 as of May 19, 2025.
Does Whitehawk Therapeutics stock pay dividends?
No, Whitehawk Therapeutics (WHWK) stock does not pay dividends to its shareholders as of May 19, 2025.
When is the next Whitehawk Therapeutics dividend payment date?
Whitehawk Therapeutics (WHWK) stock does not pay dividends to its shareholders.
What is the beta indicator for Whitehawk Therapeutics?
Whitehawk Therapeutics (WHWK) has a beta rating of 0.51. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.